首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Rearrangement of NOTCH1 or BCL3 can independently trigger progression of CLL
【24h】

Rearrangement of NOTCH1 or BCL3 can independently trigger progression of CLL

机译:NOTCH1或BCL3的重排可以独立触发CLL进展

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Recent data indicate that NOTCH 1 mutations significantly increase the risk of CLL progression toward Richter syndrome (RS) and chemoresistance, and that activation of N0TCH1 at time of CLL diagnosis is an independent prognostic factor of poor survival.1-3 We report here a case of CLL with a novel rearrangement of N0TCH1 identified at the time of RS. The patient, a 58-year-old male, was diagnosed with CLL (unmutated VH) in RS in June 2003. Cytogenetic analysis and FISH on peripheral blood (PBL), bone marrow (BM), and lymph node (LN) cells showed 2 related clones: one with an isolated +12 and a second with +12 and dic(9;14)(q34;q32) (supplemental Table 1, available on the Blood Web site; see the Supplemental Materials link at the top of the online article).
机译:最近的数据表明,NOTCH 1突变显着增加了CLL进展为Richter综合征(RS)和化学耐药性的风险,而CLL诊断时N0TCH1的激活是存活率低的独立预后因素。1-3我们在此报告一例RS时发现的CLL具有N0TCH1的新颖重排。该患者是一名58岁的男性,于2003年6月在RS中被诊断为CLL(未突变VH)。对外周血(PBL),骨髓(BM)和淋巴结(LN)细胞的细胞遗传学分析和FISH显示2个相关克隆:一个带有孤立的+12,另一个带有+12和dic(9; 14)(q34; q32)(补充表1,可在Blood网站上找到;请参见补充材料链接)。在线文章)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号